Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9611-9617
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9611
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9611
Table 1 Development of adenocarcinoma
| Ref. | Number of patients | Incidence of adenocarcinoma (n/yr follow-up) | Annual incidence of adenocarcinoma (95%CI)1 | Number of cancers expected to develop (95%CI) | Individual’s lifetime risk of adenocarcinoma (95%CI) |
| Desai et al[5] | 11434 | 186/58547 | 0.32% (0.27-0.37) | 557 (479-643) | 0.071 (0.061-0.082) |
| Yousef et al[6] | 11279 | 209/47496 | 0.44% (0.38-0.50) | 771 (670-883) | 0.098 (0.085-0.112) |
| Sikkema et al[7] | 14109 | 344/61804 | 0.56% (0.50-0.62) | 975 (874-1084) | 0.124 (0.111-0.138) |
| Thomas et al[8] | 9469 | 186/36635 | 0.51% (0.44-0.59) | 890 (766-1027) | 0.113 (0.097-0.130) |
| Gatenby et al[3] | 807 | 23/3912 | 0.59% (0.38-0.87) | 1030 (653-1546) | 0.131 (0.083-0.196) |
- Citation: Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus. World J Gastroenterol 2014; 20(28): 9611-9617
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9611.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9611